- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07228260
Help Texts Grief Intervention for Bereaved College Students
The proposed study aims to evaluate the effectiveness of Help Texts, a weekly text-based program, among bereaved students at UCLA. Specifically, the study will evaluate whether Help Texts reduces grief severity and symptoms of depression, and whether it improves academic functioning (e.g., graduation, grades, student enrollment retention).
The investigators hypothesize that bereaved UCLA students who receive a 12-month Help Texts weekly digital text intervention will have reduced grief severity and depressive symptoms and increased academic functioning compared to bereaved UCLA students in a waitlist control condition receiving treatment as usual (i.e., list of resources for grief).
Participants will complete surveys at four timepoints: baseline and 3 months, 6 months, and 12 months following enrollment. They will be randomly assigned to either the treatment condition (receive 12-month Help Texts subscription at enrollment) or the waitlist control condition (receive list of resources for grief at enrollment, and receive 12-month Help Texts subscription at 6 months following enrollment). The Help Texts program involves texts offering psychoeducation related to grief and coping strategies, delivered twice weekly.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Grief and loss are common occurrences among students on college campuses but are inadequately addressed and associated with a number of negative outcomes. A mixed methods study of grieving students on a large campus found that 60% of those surveyed within a 3-year period at UCLA reported experiencing the loss of a loved one, but only 8% reported using campus resources to aid them during their grief, and only 38% sought resources off-campus (e.g., therapy, support groups, psychiatry). Numerous barriers to accessing grief support resources have been identified, including not knowing about them or perceiving them to be inadequate. Moreover, over one-third of participants interviewed in the study noted stigma associated with help-seeking. Despite a high prevalence of experiences of grief among students, resource utilization for supporting bereavement remains low.
Help Texts offers text message-based grief support, overcoming the barriers of access and stigma by providing up to a year of private, evidence-based grief support developed by clinical psychologists. Help Texts is an established company (specifically, a Public Benefit Corporation) and is currently in use. It was founded in 2018 and comprises a fully remote, 7-person team with over 100+ additional Expert Contributors providing expertise on different types of loss (e.g., the loss of a sibling, child, parent, partner; loss to cancer, dementia, suicide, COVID-19, etc); and the unique risks associated with being a caregiver, veteran, or member of the LGBTQIA2S+ or Black, Indigenous, and People of Color (BIPOC) communities. Help Texts is delivering support in 57 countries, in all 50 states in the U.S., and in 27 languages.
Help Texts provides twice-weekly, one-way texts offering basic grief education by normalizing and validating the grief experience and then offering tips for coping within various themes around grief. Preliminary evidence suggests that bereaved users of HelpTexts have found it supportive; 95% of all users rated their satisfaction with HelpTexts as a 4 or 5 out of 5 and found the text messages helpful. The proposed study is a randomized control trial that aims to evaluate the effectiveness of Help Texts to grieving students at UCLA in reducing grief severity and symptoms of depression, preventing prolonged grief and major depressive disorder, and in improving quality of life and occupational functioning (e.g., graduation, grades, student enrollment retention).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michelle Chang, M.A., C.Phil
- Phone Number: (323) 284-4695
- Email: changmichelle@g.ucla.edu
Study Contact Backup
- Name: Theodore F. Robles, Ph.D.
- Phone Number: (310) 794-9362
- Email: robles@psych.ucla.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- Recruiting
- Franz Hall
-
Contact:
- Michelle Chang, M.A.
- Phone Number: 3232844695
- Email: griefstudy@ucla.edu
-
Principal Investigator:
- Theodore Robles, Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Enrolled UCLA student
- At least 18 years old
- Experienced death of a close person in the past 12 months
- Able to read English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Waitlist Control with Treatment as Usual
At study enrollment, participants receive treatment as usual--a list of resources relevant to grief. At 6 months following study enrollment, participants will receive a 12-month subscription to Help Texts, a text-based intervention that delivers two texts per week providing bereavement psychoeducation, validation, and coping strategies. |
Participants will receive treatment as usual, consisting of a list of resources for coping with grief both on-campus and off-campus
Help Texts delivers texts twice a week over a period of 12-months to provide psychoeducation, validation, and coping strategies relevant to bereavement.
The The texts offer some customization in specifying the name of the participant and their deceased loved one, as well as providing texts relevant to the participants' cause of bereavement and relationship to their deceased loved one.
Other Names:
|
|
Active Comparator: Treatment
At study enrollment, participants will receive a 12-month subscription to Help Texts, a text- based intervention that delivers two texts per week providing bereavement psychoeducation, validation, and coping strategies.
|
Help Texts delivers texts twice a week over a period of 12-months to provide psychoeducation, validation, and coping strategies relevant to bereavement.
The The texts offer some customization in specifying the name of the participant and their deceased loved one, as well as providing texts relevant to the participants' cause of bereavement and relationship to their deceased loved one.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prolonged Grief Disorder-Revised (PG-13-R)
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
PG-13-R measures symptoms of Prolonged Grief Disorder (PGD) mapping onto the Diagnostic and Statistical Manual's conceptualization of clinical grief.
The measure assesses symptoms such as yearning for the deceased close person, avoiding reminders of their death, and feelings of loneliness in relation to the death.
Each item is rated from 1 (Not at all) to 5 (Overwhelmingly).
Total scores range from 10 to 50, with higher scores representing more severe prolonged grief.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
|
Patient Health Questionnaire (PHQ-3)
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
The PHQ-3 measures symptoms of depression over the last 2 weeks, including loss of interest in things, feeling down or hopeless, and feeling tired.
Each item is rated from 0 (Not at all) to 3 (Nearly every day).
Total scores range from 0 to 9, with higher scores representing more severe symptoms of depression.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Academic Functioning - GPA
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
Participants' current overall GPA will be measured.
From highest to lowest, the GPA options will be the following: A+, A, A-, B+, B, B-, C+, C, C-, D+ or below, with A+ representing the highest possible current overall GPA.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
|
Academic Functioning - Negative Impacts to Academic Performance
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
The investigators will assess the number of days that participants felt that emotional or mental difficulties hurt their academic performance.
Participants can select the following options: None (0), 1-2 days (1), 3-5 days (2), 6 or more days (3), with scores ranging from 0 to 3. Higher scores indicate more days that participants felt their academic performance was hurt by their emotional or mental difficulties.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
|
Academic Functioning - Class Enrollment Status
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
Participants will indicate whether or not they are currently registered for classes at UCLA.
They will respond Yes (1) or No (0), with a higher score indicating that they are currently registered for classes.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
|
Academic Functioning - Dropped Course
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
Another academic outcome measured will be whether or not participants dropped a course in the past quarter.
This will be dichotomously scored as Yes (1) or No (0), with a higher score indicating endorsement of having dropped a course in the past quarter.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 0 months, 3 months, 6 months, 12 months following enrollment
|
The GAD-7 will assess symptoms of generalized anxiety over the past 2 weeks consistent with the Diagnostic and Statistical Manual's conceptualization of generalized anxiety.
It will assess symptoms such as being unable to control worrying and having difficulty relaxing.
Items will be scored from 0 (Not at all) to 3 (Nearly every day).
Total scores will range from 0 to 21, with higher scores indicating more severe symptoms of generalized anxiety.
|
0 months, 3 months, 6 months, 12 months following enrollment
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Levesque DA, Lunardini MM, Adams SN, Payne EL, Neumann BG. Grief Coach: Feasibility and acceptability of a text message program for bereavement support among grievers in the United Kingdom. Death Stud. 2025;49(4):391-402. doi: 10.1080/07481187.2024.2334080. Epub 2024 Apr 4.
- Chang M, Panda S, Tajrian M, Kim WI, Dunkel Schetter C, Robles TF. Bereavement, resource utilization, and collective grieving since the COVID pandemic: Mixed-methods study of university students and staff. 2024.
- Varga MA, Lanier B, Biber D, Stewart B. Holistic Grief Effects, Mental Health, and Counseling Support in Bereaved College Students. College Student Affairs Journal. 2021;39(1):1-13. doi: 10.1353/csj.2021.0000.
- Sirrine EH, Kliner O, Gollery TJ. College Student Experiences of Grief and Loss Amid the COVID-19 Global Pandemic. Omega (Westport). 2023 Aug;87(3):745-764. doi: 10.1177/00302228211027461. Epub 2021 Jun 23.
- Jones S, Martini M. Sense of self, depression and adaption to grief, in emerging adults who suffered parental loss. Current Psychology. 2023;42(7):5212-25. doi: 10.1007/s12144-021-01843-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB-25-0709
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bereavement
-
University of ZurichSwiss Transfusion SRCCompletedBereavementSwitzerland
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted
-
New York City Health and Hospitals CorporationNot yet recruiting
-
Servicio Canario de SaludCompleted
-
University of California, Los AngelesCompleted
-
East Carolina UniversityAkron Children's Hospital; Palliative Care Research Cooperative GroupCompleted
-
St. Jude Children's Research HospitalCompleted
-
Beckley Med FoundationEnrolling by invitation
Clinical Trials on list of resources for grief
-
Unity Health TorontoNot yet recruitingCounseling | Sexual and Gender Minorities | Pre-Exposure Prophylaxis (PrEP)Canada
-
Unity Health TorontoOntario Ministry of Health and Long Term Care; Ontario Medical Association; Platinum... and other collaboratorsRecruitingQuality of Life | Mental Health | Emotional DistressCanada
-
University of Wisconsin, MadisonNot yet recruiting
-
Johns Hopkins UniversityThe Commonwealth FundCompletedLow-income Children's Well-child Care VisitUnited States
-
University of AarhusDanish Cancer Society; TrygFonden, Denmark; Dæhnfeldt FoundationCompleted
-
Uppsala UniversityRecruitingProlonged Grief DisorderSweden
-
Ludwig-Maximilians - University of MunichCompleted
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)CompletedHepatitis B | Liver Neoplasms
-
National Institute on Alcohol Abuse and Alcoholism...UnknownAlcohol Dependence | Alcohol Related MorbidityUnited States
-
New York State Psychiatric InstituteThe Robin Hood FoundationCompletedPostpartum Depression | Infant Development | Rhythm; SleepUnited States